Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
NZ768504B2 - Composition for improving skin conditions - Google Patents
[go: Go Back, main page]

NZ768504B2 - Composition for improving skin conditions - Google Patents

Composition for improving skin conditions

Info

Publication number
NZ768504B2
NZ768504B2 NZ768504A NZ76850419A NZ768504B2 NZ 768504 B2 NZ768504 B2 NZ 768504B2 NZ 768504 A NZ768504 A NZ 768504A NZ 76850419 A NZ76850419 A NZ 76850419A NZ 768504 B2 NZ768504 B2 NZ 768504B2
Authority
NZ
New Zealand
Prior art keywords
lactococcus
skin
bacterium
use according
skin condition
Prior art date
Application number
NZ768504A
Other versions
NZ768504A (en
Inventor
Toshio Fujii
Takeshi Kokubo
Munekimi NANAO
Ryohei Tsuji
Original Assignee
Kirin Holdings Kabushiki Kaisha
Filing date
Publication date
Priority claimed from JP2018048311A external-priority patent/JP6846376B2/en
Application filed by Kirin Holdings Kabushiki Kaisha filed Critical Kirin Holdings Kabushiki Kaisha
Publication of NZ768504A publication Critical patent/NZ768504A/en
Publication of NZ768504B2 publication Critical patent/NZ768504B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Abstract

The purpose of the present invention is to provide a novel food material that is efficacious in improving skin conditions. Provided is a composition for improving skin conditions, said composition comprising a bacterium belonging to the genus Lactococcus as an active ingredient. As an example of the bacterium belonging to the genus Lactococcus, Lactococcus lactis can be cited. Examples of the skin conditions to be improved include skin conditions worsened by exposure to light such as reddish skin and skin with reduced moisture content. Disclosed is use of a Lactococcus lactis subsp. lactis JCM5805 for the manufacture of a medicament for therapeutically treating, preventing, or improving a deteriorated skin condition with photodermatosis and a non-therapeutic method for improving skin conditions by feeding or administering an effective amount of Lactococcus lactis subsp. lactis JCM5805.

Claims (14)

1. Use of a Lactococcus bacterium or a composition comprising a Lactococcus bacterium for the manufacture of a medicament for therapeutically treating, preventing, or improving a deteriorated skin condition with photodermatosis in a subject, wherein the Lactococcus bacterium is Lactococcus lactis subsp. lactis JCM5805.
2. The use according to claim 1, wherein the photodermatosis comprises solar dermatitis, sunburn, photoaging, or photosensitivity.
3. The use according to claim 1 or 2, wherein the skin condition is a skin condition deteriorated by light exposure.
4. The use according to claim 3, wherein the skin condition deteriorated by light exposure is a decrease in skin moisture content and/or an increase in skin redness.
5. The use according to any one of claims 1 to 4, wherein the Lactococcus bacterium is in the form of a dead bacterium.
6. The use according to any one of claims 1 to 5, wherein the medicament comprises an effective daily intake amount of the Lactococcus bacterium for a human.
7. The use according to claim 6, wherein the effective daily intake amount for a human ranges from 0.5 to 1000 mg on the basis of dried bacterial powder.
8. The use according to claim 7, wherein the effective daily intake amount for a human ranges from 1×10 to 1×10 on the basis of the number of bacteria.
9. The use according to any one of claims 1 to 8, wherein the medicament is in the form of a unit package.
10. A non-therapeutic method for improving a skin condition, comprising feeding or administering an effective amount of a Lactococcus bacterium or a composition comprising the same to a subject in need thereof, wherein the Lactococcus bacterium is Lactococcus lactis subsp. lactis JCM5805.
11. The method according to claim 10, wherein the skin condition is a skin condition deteriorated by light exposure.
12. The method according to claim 11, wherein the skin condition deteriorated by light exposure is a decrease in skin moisture content and/or an increase in skin redness.
13. The method according to any one of claims 10 to 12, which comprises the Lactococcus bacterium in the form of a dead bacterium.
14. The method according to any one of claims 10 to 13, wherein the Lactococcus bacterium or composition comprising the same is in a food composition.
NZ768504A 2019-03-15 Composition for improving skin conditions NZ768504B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018048311A JP6846376B2 (en) 2018-03-15 2018-03-15 Composition for improving skin condition
PCT/JP2019/010773 WO2019177139A1 (en) 2018-03-15 2019-03-15 Composition for improving skin conditions

Publications (2)

Publication Number Publication Date
NZ768504A NZ768504A (en) 2025-08-29
NZ768504B2 true NZ768504B2 (en) 2025-12-02

Family

ID=

Similar Documents

Publication Publication Date Title
Teanpaisan et al. In vitro antimicrobial and antibiofilm activity of Artocarpus lakoocha (Moraceae) extract against some oral pathogens
Geoghegan et al. Inhibitory effect of quercetin on periodontal pathogens in vitro
Ko et al. Relationship between chemical structure and antimicrobial activities of isothiocyanates from cruciferous vegetables against oral pathogens
Bomdyal et al. Antibacterial activity of curcumin (turmeric) against periopathogens-An in vitro evaluation
TW201922224A (en) Antibacterial cosmetic composition comprising Lactobacillus plantarum culture
CN106573023A (en) Lactobacillus plantarum CNCM I-4026 preparations and skin health
Herman Comparison of antimicrobial activity of essential oils, plant extracts and methylparaben in cosmetic emulsions: 2 months study
WO2012017349A3 (en) Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
Safii et al. Periodontal application of manuka honey: Antimicrobial and demineralising effects in vitro
RU2009100890A (en) PREVENTION AND TREATMENT OF MIDDLE EAR INFLAMMATION BY USING NON-PATHOGENIC BACTERIA STRAINS
da Silva Oliveira et al. Nisin variants: What makes them different and unique?
JP2019156793A5 (en)
Majbauddin et al. The effect of bamboo leaf extract solution and sodium copper chlorophyllin solution on growth and volatile sulfur compounds production of oral malodor associated some anaerobic periodontal bacteria
KR20180008071A (en) Cosmetic composition for improving skin inflammation comprising fermentated extract of inula britannica flowers and method for prparing thereof
Tamura et al. Exploring the possible applications of catechin (gel) for oral care of the elderly and disabled individuals
CN102905699A (en) Anti-fungal agent
ZA200600866B (en) Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection
Das et al. Antimicrobial effect of edible plant extract on the growth of some foodborne bacteria including pathogens
NZ768504B2 (en) Composition for improving skin conditions
Shafi et al. In vitro antibacterial activity and minimum inhibitory concentration of Ocimum sanctum leaves against common bovine mastitis pathogens
NZ768504A (en) Composition for improving skin conditions
Kulik et al. Antimicrobial effects of tea tree oil (Melaleuca alternifolia) on oral microorganisms
CN101020072A (en) Deodorizing bacteriostatic mildewproof powder prepn
CN104430431B (en) A kind of composition containing fludioxonil and chlorine nalidixic bacterium ester
Adapa et al. In vitro antimicrobial activity of Spinacia oleracea against Streptococcus mutans and Lactobacillus acidophilus